SlideShare uma empresa Scribd logo
1 de 32
Baixar para ler offline
Give me your brain: Communicating
          Tricky Topics
  Discussion points:
  •Tissue donation to medical research
  •‘Treatments’ that aren’t all they’re cracked up to be
  •Managing expectations – new drugs, patents and approvals
  •Open access by public – how do we keep on top of the
  information in the public sphere?


 Continue the conversation after the conference at
   communicatingtrickytopics.wordpress.com
 #SciCommConf
How do we talk to people
 about ‘dementia risk’?
Jess Smith, Research Communications Officer
What does the evidence show?
• Exercise is beneficial – can reduce the risk of
  developing dementia by 25-50%
• High blood pressure is a risk factor – risk of
  dementia is 1.5 – 3 times higher.
• High cholesterol is a risk factor – risk of
  dementia is 1.5 – 3 times higher.
• Healthy diet and exercise are advocated as
  ways to reduce your risk.

                                   alzheimers.org.uk/research
People affected by dementia
• Don’t assign ‘blame’
• Focus on positive message – what can
  they do now?
• Focus on positive (not genetics etc)




                           alzheimers.org.uk/research
General public
• Focus on prevention
• Exercise, diet
• Not anything specific – no ‘superfoods’ or
  crossword puzzles!




                              alzheimers.org.uk/research
Press
•   Really clear
•   General messaging
•   No specifics
•   No superfoods or crossword puzzles!
•   Give quotable items – nice sounding
    messages.

                              alzheimers.org.uk/research
Jo Brodie – Diabetes UK
• Islet cell transplants in Type 1
  diabetes.
• background to Type 1 diabetes
• What is islet cell transplant?
• Is it a ‘miracle cure’?
Making a personal choice



Kelly Edwards
Research Information Co-ordinator
Motor Neurone Disease Association
Kelly.edwards@mndassociation.org
The role of patient organisations
• Patient organisation role to provide the facts
  about unproven/off-label treatments

• Allow people to make a well-informed personal
  choice
Eg: Off-label lithium and MND
• Lithium is already prescribed as a mood-
  stabilising drug for mood-related disorders

• Available off-label

• Interest in lithium for MND from a patient’s
  perspective sky rocketed when a poorly
  designed trial published their ‘amazing’
  results.
President of the                              Person with MND,
royal college of                              who took lithium off
physicians                                    label.
                                              "That's easy to say
"While the                                    when you're not the
information is                                one faced with the
encouraging, it's                             decision.”
important to await
results of clinical
trials because the     Patient                "I'm willing to take the
medicine has           Organisations bridge   chance if I
                                              understand the
serious side-effects   the gap between
which could                                   science and the risk.”
                       people affected by
potentially make
                       disease and the
some of the
symptoms worse."       medical profession.
ALSUntangled
•   ALSUntangled use social
    networking to bring patients,
    clinicians, and scientists together
    for investigation of alternative or
    off-label MND Treatments.

•   15 investigations completed,
    including X-Cell stem cell clinic,
    Bee Venom therapy and coconut
    oil.

•   Results are published in the journal
    ALS, are open access and are
    written in an accessible way.
Summary
•   Opinion on unproven treatments changes with perspective – this is
    important to bear in mind when tackling unproven or off-label
    treatment stories.

•   Patient organisations understand both why people would want to
    pursue these options, as well as why people should be careful.

•   As well as patient organisations, resources such as those created
    by ALSUntangled provide the sort of objective information that helps
    people to come to an informed choice on whether or not to pursue
    alternative approaches to treating their disease.
Donating your body to
  medical science
Funded by UCL Public Engagement
        Dr Jenny Gimpel
Would you donate your body to medicine after your death?
             If so, how do you go about it?

     Why do medical schools need human bodies?
  What happens to the bodies during and after teaching?

         Join us for a public discussion on

Donating your body to medical science
           7.30pm Tuesday 20 April 2010

       Bloomsbury Suite, Friends House,
      173 Euston Road, London, NW1 2BJ
                          Speakers include:
       Vishy Mahadevan, Royal College of Surgeons
          Wendy Birch, University College London
           Louise Evans, London Anatomy Office
          Shaun Griffin, Human Tissue Authority
        To register for a place, please contact Jenny Gimpel
       on tel: 07855 788985, email: jennygimpel@gmail.com.

 The event is free, but places are on a first-come first-served basis.
       Refreshments will be provided. Doors open at 7pm.

         Nearest tube stations Euston and Euston Square.
            Wheelchair access, induction loops fitted.
SCC 2012 Give me your brain: communicating tricky topics
Importance of consent and informing family
Possibility of rejection if donation unsuitable




      Bodies increasingly used in surgical training
           Military medics train on human cadavers
How many bodies are donated and are there enough?

              What do you do with the bodies?

What if you have a donor card as well as a consent form?

Is diabetes a criterion for rejection?

    Why don’t you take obese bodies to practice surgery on,
                         given the current health problem?
Public – Rejection was biggest issue

            “Hate idea that after deciding to donate,
                                   might be refused.”

               “The subject needs more publicity.”



Organisers – Want to do a larger-scale event
Initial reluctance within UCL

      No negative reaction from public

Less support from GP surgeries
Human Tissue Authority
150 calls a month
Donor webpage in top 5 visited

      No national
      data on
      body
      donations!
Thanks to
University College London
London Anatomy Office
Royal College of Surgeons
Human Tissue Authority
Tissue Access for Patient Benefit
            (TAPb)


             Dr Amir Gander
          Department of Surgery
           Royal Free Hospital
TAPB
What we
     wanted
• Public and patients
  involved with
  research

• Raise awareness

• Data from
  patient/public vs.
  professional
Improving Liver Transplant
          Outcomes, Your View
• We wanted:




               Clinical professionals/researchers
What we got….
             Patients/public




Clinical professionals/researchers
What we learnt
• Inflexibility


• Patients invited by doctor = doctor


• People want to make a difference
• Similar title!!


• Voting system


• Comment boards
We have data!
      88%           After this conference
                    are you more or less
                       likely to donate
Yes
                            tissue?




             No     Need more information
                    8%
             4%

      1       2       3
Patients running away!
                                                                                                       47%

                                             41%




Patient                Professionals                    Patient                   Professionals



                                                                                                 24%
  21%

                                       18%




                                                           12%              12%

                  9%

                                                   6%                                  6%

        3%                  3%

             0%        0%         0%                              0%   0%         0%        0%               0%


  1     2    3    4    5    6     7     8     9    10      1      2    3    4     5    6     7    8     9    10
Conclusions
• Data is key

• Crucial to influence our research and policy makers:
   • Patients and public less cautious than professionals
   • Mutual benefit leads to representative audience

• We need to be more representative

• Build momentum slowly

Mais conteúdo relacionado

Mais procurados

Evidence Based Practice: Pediatrics, Binocular Vision and Patients with Speci...
Evidence Based Practice: Pediatrics, Binocular Vision and Patients with Speci...Evidence Based Practice: Pediatrics, Binocular Vision and Patients with Speci...
Evidence Based Practice: Pediatrics, Binocular Vision and Patients with Speci...Dominick Maino
 
060915 current research that you should incorporate into your
060915 current research that you should incorporate into your060915 current research that you should incorporate into your
060915 current research that you should incorporate into yourDominick Maino
 
Va open notes and blue button va ehealth university dec 2012
Va open notes and blue button va ehealth university dec 2012Va open notes and blue button va ehealth university dec 2012
Va open notes and blue button va ehealth university dec 2012Susan Woods
 
Indonesia assist and hr2014
Indonesia assist and hr2014Indonesia assist and hr2014
Indonesia assist and hr2014ditkeswa
 
Superpatients webinar for Natl Network of Libraries of Medicine
Superpatients webinar for Natl Network of Libraries of MedicineSuperpatients webinar for Natl Network of Libraries of Medicine
Superpatients webinar for Natl Network of Libraries of Medicinee-Patient Dave deBronkart
 
Simulated 3D: Research, Education and In Your Office
Simulated 3D: Research, Education and In Your OfficeSimulated 3D: Research, Education and In Your Office
Simulated 3D: Research, Education and In Your OfficeDominick Maino
 
Shared decision making
Shared decision makingShared decision making
Shared decision makingChai-Eng Tan
 
Pharmanex HCP presentation, Provo, Utah 03
Pharmanex HCP presentation, Provo, Utah 03 Pharmanex HCP presentation, Provo, Utah 03
Pharmanex HCP presentation, Provo, Utah 03 Louis Cady, MD
 
Referral to Physical Therapy Lowers Care Utilization for LBP vs Referral for ...
Referral to Physical Therapy Lowers Care Utilization for LBP vs Referral for ...Referral to Physical Therapy Lowers Care Utilization for LBP vs Referral for ...
Referral to Physical Therapy Lowers Care Utilization for LBP vs Referral for ...fortunatequilt157
 
HealthPanel Concept pitchdeck
HealthPanel Concept pitchdeckHealthPanel Concept pitchdeck
HealthPanel Concept pitchdecksmworth
 
DayOne Accelerator 2019/20 shortlisted projects
DayOne Accelerator 2019/20 shortlisted projectsDayOne Accelerator 2019/20 shortlisted projects
DayOne Accelerator 2019/20 shortlisted projectsDayOne
 
Communication During Transitions of Care: how well is it really working?
Communication During Transitions of Care: how well is it really working?Communication During Transitions of Care: how well is it really working?
Communication During Transitions of Care: how well is it really working?Canadian Patient Safety Institute
 
Epidemiology of patients with poor prognosis at ICU admission – prevalence, ...
Epidemiology of patients with poor prognosis at ICU admission –  prevalence, ...Epidemiology of patients with poor prognosis at ICU admission –  prevalence, ...
Epidemiology of patients with poor prognosis at ICU admission – prevalence, ...SMACC Conference
 
Choosing Wisely Primer
Choosing Wisely PrimerChoosing Wisely Primer
Choosing Wisely PrimerMick Brown
 

Mais procurados (20)

Evidence Based Practice: Pediatrics, Binocular Vision and Patients with Speci...
Evidence Based Practice: Pediatrics, Binocular Vision and Patients with Speci...Evidence Based Practice: Pediatrics, Binocular Vision and Patients with Speci...
Evidence Based Practice: Pediatrics, Binocular Vision and Patients with Speci...
 
060915 current research that you should incorporate into your
060915 current research that you should incorporate into your060915 current research that you should incorporate into your
060915 current research that you should incorporate into your
 
Va open notes and blue button va ehealth university dec 2012
Va open notes and blue button va ehealth university dec 2012Va open notes and blue button va ehealth university dec 2012
Va open notes and blue button va ehealth university dec 2012
 
Indonesia assist and hr2014
Indonesia assist and hr2014Indonesia assist and hr2014
Indonesia assist and hr2014
 
Evisit Mneug B
Evisit Mneug BEvisit Mneug B
Evisit Mneug B
 
Superpatients webinar for Natl Network of Libraries of Medicine
Superpatients webinar for Natl Network of Libraries of MedicineSuperpatients webinar for Natl Network of Libraries of Medicine
Superpatients webinar for Natl Network of Libraries of Medicine
 
Simulated 3D: Research, Education and In Your Office
Simulated 3D: Research, Education and In Your OfficeSimulated 3D: Research, Education and In Your Office
Simulated 3D: Research, Education and In Your Office
 
A Reporter's Guide to Medical Decision Making
A Reporter's Guide to Medical Decision MakingA Reporter's Guide to Medical Decision Making
A Reporter's Guide to Medical Decision Making
 
Shared decision making
Shared decision makingShared decision making
Shared decision making
 
Pharmanex HCP presentation, Provo, Utah 03
Pharmanex HCP presentation, Provo, Utah 03 Pharmanex HCP presentation, Provo, Utah 03
Pharmanex HCP presentation, Provo, Utah 03
 
Referral to Physical Therapy Lowers Care Utilization for LBP vs Referral for ...
Referral to Physical Therapy Lowers Care Utilization for LBP vs Referral for ...Referral to Physical Therapy Lowers Care Utilization for LBP vs Referral for ...
Referral to Physical Therapy Lowers Care Utilization for LBP vs Referral for ...
 
HealthPanel Concept pitchdeck
HealthPanel Concept pitchdeckHealthPanel Concept pitchdeck
HealthPanel Concept pitchdeck
 
DayOne Accelerator 2019/20 shortlisted projects
DayOne Accelerator 2019/20 shortlisted projectsDayOne Accelerator 2019/20 shortlisted projects
DayOne Accelerator 2019/20 shortlisted projects
 
The Attending Model Of Medicine
The Attending Model Of MedicineThe Attending Model Of Medicine
The Attending Model Of Medicine
 
Communication During Transitions of Care: how well is it really working?
Communication During Transitions of Care: how well is it really working?Communication During Transitions of Care: how well is it really working?
Communication During Transitions of Care: how well is it really working?
 
Sharing EHRs - A GP and patient perspective
Sharing EHRs - A GP and patient perspectiveSharing EHRs - A GP and patient perspective
Sharing EHRs - A GP and patient perspective
 
Epidemiology of patients with poor prognosis at ICU admission – prevalence, ...
Epidemiology of patients with poor prognosis at ICU admission –  prevalence, ...Epidemiology of patients with poor prognosis at ICU admission –  prevalence, ...
Epidemiology of patients with poor prognosis at ICU admission – prevalence, ...
 
Smoking cessation for residents
Smoking cessation for residentsSmoking cessation for residents
Smoking cessation for residents
 
Intro to Shared Decision Making
Intro to Shared Decision MakingIntro to Shared Decision Making
Intro to Shared Decision Making
 
Choosing Wisely Primer
Choosing Wisely PrimerChoosing Wisely Primer
Choosing Wisely Primer
 

Semelhante a SCC 2012 Give me your brain: communicating tricky topics

Patient Engagement and Empowerment: A Culture War Begins
Patient Engagement and Empowerment: A Culture War BeginsPatient Engagement and Empowerment: A Culture War Begins
Patient Engagement and Empowerment: A Culture War Beginse-Patient Dave deBronkart
 
Schwitzer keynote to ISDM 2013 Lima, Peru
Schwitzer keynote to ISDM 2013 Lima, PeruSchwitzer keynote to ISDM 2013 Lima, Peru
Schwitzer keynote to ISDM 2013 Lima, PeruGary Schwitzer
 
Evaluating medical evidence for journalists
Evaluating medical evidence for journalistsEvaluating medical evidence for journalists
Evaluating medical evidence for journalistsIvan Oransky
 
Doctors & Patients on the Same Page: #SIIM18 opening keynote
Doctors & Patients on the Same Page: #SIIM18 opening keynoteDoctors & Patients on the Same Page: #SIIM18 opening keynote
Doctors & Patients on the Same Page: #SIIM18 opening keynotee-Patient Dave deBronkart
 
Patient Satisfaction: the big clue to what works in the patient's life
Patient Satisfaction: the big clue to what works in the patient's lifePatient Satisfaction: the big clue to what works in the patient's life
Patient Satisfaction: the big clue to what works in the patient's lifee-Patient Dave deBronkart
 
MedicalResearch.com: Medical Research Exclusive Interviews July 24 2015
MedicalResearch.com:  Medical Research Exclusive Interviews July 24 2015MedicalResearch.com:  Medical Research Exclusive Interviews July 24 2015
MedicalResearch.com: Medical Research Exclusive Interviews July 24 2015Marie Benz MD FAAD
 
"Patient Engagement is Changing What’s Possible" - Alberta Health Services ...
"Patient Engagement is Changing What’s Possible" - Alberta Health Services ..."Patient Engagement is Changing What’s Possible" - Alberta Health Services ...
"Patient Engagement is Changing What’s Possible" - Alberta Health Services ...e-Patient Dave deBronkart
 
Covering Cancer Treatments: Tricks of the Trade
Covering Cancer Treatments: Tricks of the TradeCovering Cancer Treatments: Tricks of the Trade
Covering Cancer Treatments: Tricks of the TradeIvan Oransky
 
"Think, think, think": e-Patient Dave address to ECPC annual meeting
"Think, think, think": e-Patient Dave address to ECPC annual meeting"Think, think, think": e-Patient Dave address to ECPC annual meeting
"Think, think, think": e-Patient Dave address to ECPC annual meetinge-Patient Dave deBronkart
 
2010 11 13 european cme forum jan geissler 1.5
2010 11 13 european cme forum jan geissler 1.52010 11 13 european cme forum jan geissler 1.5
2010 11 13 european cme forum jan geissler 1.5jangeissler
 
"e-Patients are Changing Healthcare": Public keynote at NI2016, Geneva
"e-Patients are Changing Healthcare": Public keynote at NI2016, Geneva"e-Patients are Changing Healthcare": Public keynote at NI2016, Geneva
"e-Patients are Changing Healthcare": Public keynote at NI2016, Genevae-Patient Dave deBronkart
 
"I'm gonna live live live live live until I die" - palliative care
"I'm gonna live live live live live until I die" - palliative care"I'm gonna live live live live live until I die" - palliative care
"I'm gonna live live live live live until I die" - palliative caree-Patient Dave deBronkart
 
MedicalResearch.com: Medical Research Interviews October 6 2014
MedicalResearch.com:  Medical Research Interviews October 6  2014MedicalResearch.com:  Medical Research Interviews October 6  2014
MedicalResearch.com: Medical Research Interviews October 6 2014Marie Benz MD FAAD
 
Using Patient Reported Outcomes to Inform Offlabel Prescribing
Using Patient Reported Outcomes to Inform Offlabel PrescribingUsing Patient Reported Outcomes to Inform Offlabel Prescribing
Using Patient Reported Outcomes to Inform Offlabel PrescribingACSM @ VU University Amsterdam
 
Media project social impact of technology
Media project  social impact of technologyMedia project  social impact of technology
Media project social impact of technologylhanousek
 
Raising Public Awareness of Clinical Trials: Tools for Engagement (H. Massett)
Raising Public Awareness of Clinical Trials: Tools for Engagement (H. Massett)Raising Public Awareness of Clinical Trials: Tools for Engagement (H. Massett)
Raising Public Awareness of Clinical Trials: Tools for Engagement (H. Massett)Esmeralda Casas-Silva, Ph.D.
 
"This is how i want to die" DPT Study Day 16th September 2011
"This is how i want to die" DPT Study Day 16th September 2011"This is how i want to die" DPT Study Day 16th September 2011
"This is how i want to die" DPT Study Day 16th September 2011Hospiscare
 

Semelhante a SCC 2012 Give me your brain: communicating tricky topics (20)

Patient Engagement and Empowerment: A Culture War Begins
Patient Engagement and Empowerment: A Culture War BeginsPatient Engagement and Empowerment: A Culture War Begins
Patient Engagement and Empowerment: A Culture War Begins
 
Schwitzer keynote to ISDM 2013 Lima, Peru
Schwitzer keynote to ISDM 2013 Lima, PeruSchwitzer keynote to ISDM 2013 Lima, Peru
Schwitzer keynote to ISDM 2013 Lima, Peru
 
Evaluating medical evidence for journalists
Evaluating medical evidence for journalistsEvaluating medical evidence for journalists
Evaluating medical evidence for journalists
 
Doctors & Patients on the Same Page: #SIIM18 opening keynote
Doctors & Patients on the Same Page: #SIIM18 opening keynoteDoctors & Patients on the Same Page: #SIIM18 opening keynote
Doctors & Patients on the Same Page: #SIIM18 opening keynote
 
Patient Satisfaction: the big clue to what works in the patient's life
Patient Satisfaction: the big clue to what works in the patient's lifePatient Satisfaction: the big clue to what works in the patient's life
Patient Satisfaction: the big clue to what works in the patient's life
 
MedicalResearch.com: Medical Research Exclusive Interviews July 24 2015
MedicalResearch.com:  Medical Research Exclusive Interviews July 24 2015MedicalResearch.com:  Medical Research Exclusive Interviews July 24 2015
MedicalResearch.com: Medical Research Exclusive Interviews July 24 2015
 
"Patient Engagement is Changing What’s Possible" - Alberta Health Services ...
"Patient Engagement is Changing What’s Possible" - Alberta Health Services ..."Patient Engagement is Changing What’s Possible" - Alberta Health Services ...
"Patient Engagement is Changing What’s Possible" - Alberta Health Services ...
 
Covering Cancer Treatments: Tricks of the Trade
Covering Cancer Treatments: Tricks of the TradeCovering Cancer Treatments: Tricks of the Trade
Covering Cancer Treatments: Tricks of the Trade
 
"Think, think, think": e-Patient Dave address to ECPC annual meeting
"Think, think, think": e-Patient Dave address to ECPC annual meeting"Think, think, think": e-Patient Dave address to ECPC annual meeting
"Think, think, think": e-Patient Dave address to ECPC annual meeting
 
2010 11 13 european cme forum jan geissler 1.5
2010 11 13 european cme forum jan geissler 1.52010 11 13 european cme forum jan geissler 1.5
2010 11 13 european cme forum jan geissler 1.5
 
"e-Patients are Changing Healthcare": Public keynote at NI2016, Geneva
"e-Patients are Changing Healthcare": Public keynote at NI2016, Geneva"e-Patients are Changing Healthcare": Public keynote at NI2016, Geneva
"e-Patients are Changing Healthcare": Public keynote at NI2016, Geneva
 
"I'm gonna live live live live live until I die" - palliative care
"I'm gonna live live live live live until I die" - palliative care"I'm gonna live live live live live until I die" - palliative care
"I'm gonna live live live live live until I die" - palliative care
 
MedicalResearch.com: Medical Research Interviews October 6 2014
MedicalResearch.com:  Medical Research Interviews October 6  2014MedicalResearch.com:  Medical Research Interviews October 6  2014
MedicalResearch.com: Medical Research Interviews October 6 2014
 
Patients As Data Source
Patients As Data SourcePatients As Data Source
Patients As Data Source
 
Using Patient Reported Outcomes to Inform Offlabel Prescribing
Using Patient Reported Outcomes to Inform Offlabel PrescribingUsing Patient Reported Outcomes to Inform Offlabel Prescribing
Using Patient Reported Outcomes to Inform Offlabel Prescribing
 
Media project social impact of technology
Media project  social impact of technologyMedia project  social impact of technology
Media project social impact of technology
 
Fmcc Policy and Advocacy
Fmcc Policy and AdvocacyFmcc Policy and Advocacy
Fmcc Policy and Advocacy
 
Raising Public Awareness of Clinical Trials: Tools for Engagement (H. Massett)
Raising Public Awareness of Clinical Trials: Tools for Engagement (H. Massett)Raising Public Awareness of Clinical Trials: Tools for Engagement (H. Massett)
Raising Public Awareness of Clinical Trials: Tools for Engagement (H. Massett)
 
"This is how i want to die" DPT Study Day 16th September 2011
"This is how i want to die" DPT Study Day 16th September 2011"This is how i want to die" DPT Study Day 16th September 2011
"This is how i want to die" DPT Study Day 16th September 2011
 
Power to the Patient
Power to the PatientPower to the Patient
Power to the Patient
 

Mais de British Science Association

SCC 2014 - Data visualisation for public engagement
SCC 2014 - Data visualisation for public engagement SCC 2014 - Data visualisation for public engagement
SCC 2014 - Data visualisation for public engagement British Science Association
 
SCC 2014 - What is wellbeing and what does it mean for science communication?
SCC 2014 - What is wellbeing and what does it mean for science communication?SCC 2014 - What is wellbeing and what does it mean for science communication?
SCC 2014 - What is wellbeing and what does it mean for science communication?British Science Association
 
SCC 2014 - The role of design in science communication
SCC 2014 - The role of design in science communicationSCC 2014 - The role of design in science communication
SCC 2014 - The role of design in science communicationBritish Science Association
 
SCC 2014 - The People, the People, the People: Engaging under-served audiences
SCC 2014 - The People, the People, the People: Engaging under-served audiencesSCC 2014 - The People, the People, the People: Engaging under-served audiences
SCC 2014 - The People, the People, the People: Engaging under-served audiencesBritish Science Association
 
SCC 2014 - Setting content free: How and why you should use open licences in ...
SCC 2014 - Setting content free: How and why you should use open licences in ...SCC 2014 - Setting content free: How and why you should use open licences in ...
SCC 2014 - Setting content free: How and why you should use open licences in ...British Science Association
 
SCC 2014 - Schools and scientists: Doing research together combined
SCC 2014 - Schools and scientists: Doing research together combinedSCC 2014 - Schools and scientists: Doing research together combined
SCC 2014 - Schools and scientists: Doing research together combinedBritish Science Association
 
SCC 2014 - Introduction to science communication
SCC 2014 - Introduction to science communicationSCC 2014 - Introduction to science communication
SCC 2014 - Introduction to science communicationBritish Science Association
 
SCC 2014 - How informal science education can better inform STEM education
SCC 2014 - How informal science education can better inform STEM educationSCC 2014 - How informal science education can better inform STEM education
SCC 2014 - How informal science education can better inform STEM educationBritish Science Association
 
SCC 2014 - Day of discovery: Running your own public attitudes to science day
SCC 2014 - Day of discovery: Running your own public attitudes to science daySCC 2014 - Day of discovery: Running your own public attitudes to science day
SCC 2014 - Day of discovery: Running your own public attitudes to science dayBritish Science Association
 
SCC2013 - Introduction to science communication diagram
SCC2013 - Introduction to science communication diagramSCC2013 - Introduction to science communication diagram
SCC2013 - Introduction to science communication diagramBritish Science Association
 
SCC2013 - Developing sustainable science communication enterprises - Phil Smith
SCC2013 - Developing sustainable science communication enterprises - Phil SmithSCC2013 - Developing sustainable science communication enterprises - Phil Smith
SCC2013 - Developing sustainable science communication enterprises - Phil SmithBritish Science Association
 
SCC2013 - Developing sustainable science communication enterprises - Kay Yeoman
SCC2013 - Developing sustainable science communication enterprises - Kay YeomanSCC2013 - Developing sustainable science communication enterprises - Kay Yeoman
SCC2013 - Developing sustainable science communication enterprises - Kay YeomanBritish Science Association
 
SCC2013 - Developing sustainable science communication enterprises - Heather Rea
SCC2013 - Developing sustainable science communication enterprises - Heather ReaSCC2013 - Developing sustainable science communication enterprises - Heather Rea
SCC2013 - Developing sustainable science communication enterprises - Heather ReaBritish Science Association
 
SCC2013 - Engaging visitors through scientific discovery
SCC2013 - Engaging visitors through scientific discoverySCC2013 - Engaging visitors through scientific discovery
SCC2013 - Engaging visitors through scientific discoveryBritish Science Association
 
SCC2013 - Evaluating online engagement: Practical and critical
SCC2013 - Evaluating online engagement: Practical and criticalSCC2013 - Evaluating online engagement: Practical and critical
SCC2013 - Evaluating online engagement: Practical and criticalBritish Science Association
 
SCC2013 - Keep calm and carry on: Practical tips on how to cope when public e...
SCC2013 - Keep calm and carry on: Practical tips on how to cope when public e...SCC2013 - Keep calm and carry on: Practical tips on how to cope when public e...
SCC2013 - Keep calm and carry on: Practical tips on how to cope when public e...British Science Association
 

Mais de British Science Association (20)

Communicating risk
Communicating riskCommunicating risk
Communicating risk
 
SCC 2014 - Data visualisation for public engagement
SCC 2014 - Data visualisation for public engagement SCC 2014 - Data visualisation for public engagement
SCC 2014 - Data visualisation for public engagement
 
SCC 2014 - What is wellbeing and what does it mean for science communication?
SCC 2014 - What is wellbeing and what does it mean for science communication?SCC 2014 - What is wellbeing and what does it mean for science communication?
SCC 2014 - What is wellbeing and what does it mean for science communication?
 
SCC 2014 - The role of design in science communication
SCC 2014 - The role of design in science communicationSCC 2014 - The role of design in science communication
SCC 2014 - The role of design in science communication
 
SCC 2014 - The People, the People, the People: Engaging under-served audiences
SCC 2014 - The People, the People, the People: Engaging under-served audiencesSCC 2014 - The People, the People, the People: Engaging under-served audiences
SCC 2014 - The People, the People, the People: Engaging under-served audiences
 
SCC 2014 - Setting content free: How and why you should use open licences in ...
SCC 2014 - Setting content free: How and why you should use open licences in ...SCC 2014 - Setting content free: How and why you should use open licences in ...
SCC 2014 - Setting content free: How and why you should use open licences in ...
 
SCC 2014 - Schools and scientists: Doing research together combined
SCC 2014 - Schools and scientists: Doing research together combinedSCC 2014 - Schools and scientists: Doing research together combined
SCC 2014 - Schools and scientists: Doing research together combined
 
SCC 2014 - Introduction to science communication
SCC 2014 - Introduction to science communicationSCC 2014 - Introduction to science communication
SCC 2014 - Introduction to science communication
 
SCC 2014 - How informal science education can better inform STEM education
SCC 2014 - How informal science education can better inform STEM educationSCC 2014 - How informal science education can better inform STEM education
SCC 2014 - How informal science education can better inform STEM education
 
SCC 2014 - How science policy really works
SCC 2014 - How science policy really worksSCC 2014 - How science policy really works
SCC 2014 - How science policy really works
 
SCC 2014 - Day of discovery: Running your own public attitudes to science day
SCC 2014 - Day of discovery: Running your own public attitudes to science daySCC 2014 - Day of discovery: Running your own public attitudes to science day
SCC 2014 - Day of discovery: Running your own public attitudes to science day
 
SCC 2014 - All the fun of festivals combined
SCC 2014 - All the fun of festivals combinedSCC 2014 - All the fun of festivals combined
SCC 2014 - All the fun of festivals combined
 
SCC2013 - Introduction to science communication diagram
SCC2013 - Introduction to science communication diagramSCC2013 - Introduction to science communication diagram
SCC2013 - Introduction to science communication diagram
 
SCC2013 - What's the true cost of free?
SCC2013 - What's the true cost of free?SCC2013 - What's the true cost of free?
SCC2013 - What's the true cost of free?
 
SCC2013 - Developing sustainable science communication enterprises - Phil Smith
SCC2013 - Developing sustainable science communication enterprises - Phil SmithSCC2013 - Developing sustainable science communication enterprises - Phil Smith
SCC2013 - Developing sustainable science communication enterprises - Phil Smith
 
SCC2013 - Developing sustainable science communication enterprises - Kay Yeoman
SCC2013 - Developing sustainable science communication enterprises - Kay YeomanSCC2013 - Developing sustainable science communication enterprises - Kay Yeoman
SCC2013 - Developing sustainable science communication enterprises - Kay Yeoman
 
SCC2013 - Developing sustainable science communication enterprises - Heather Rea
SCC2013 - Developing sustainable science communication enterprises - Heather ReaSCC2013 - Developing sustainable science communication enterprises - Heather Rea
SCC2013 - Developing sustainable science communication enterprises - Heather Rea
 
SCC2013 - Engaging visitors through scientific discovery
SCC2013 - Engaging visitors through scientific discoverySCC2013 - Engaging visitors through scientific discovery
SCC2013 - Engaging visitors through scientific discovery
 
SCC2013 - Evaluating online engagement: Practical and critical
SCC2013 - Evaluating online engagement: Practical and criticalSCC2013 - Evaluating online engagement: Practical and critical
SCC2013 - Evaluating online engagement: Practical and critical
 
SCC2013 - Keep calm and carry on: Practical tips on how to cope when public e...
SCC2013 - Keep calm and carry on: Practical tips on how to cope when public e...SCC2013 - Keep calm and carry on: Practical tips on how to cope when public e...
SCC2013 - Keep calm and carry on: Practical tips on how to cope when public e...
 

Último

Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 

Último (20)

Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 

SCC 2012 Give me your brain: communicating tricky topics

  • 1. Give me your brain: Communicating Tricky Topics Discussion points: •Tissue donation to medical research •‘Treatments’ that aren’t all they’re cracked up to be •Managing expectations – new drugs, patents and approvals •Open access by public – how do we keep on top of the information in the public sphere? Continue the conversation after the conference at communicatingtrickytopics.wordpress.com #SciCommConf
  • 2. How do we talk to people about ‘dementia risk’? Jess Smith, Research Communications Officer
  • 3. What does the evidence show? • Exercise is beneficial – can reduce the risk of developing dementia by 25-50% • High blood pressure is a risk factor – risk of dementia is 1.5 – 3 times higher. • High cholesterol is a risk factor – risk of dementia is 1.5 – 3 times higher. • Healthy diet and exercise are advocated as ways to reduce your risk. alzheimers.org.uk/research
  • 4. People affected by dementia • Don’t assign ‘blame’ • Focus on positive message – what can they do now? • Focus on positive (not genetics etc) alzheimers.org.uk/research
  • 5. General public • Focus on prevention • Exercise, diet • Not anything specific – no ‘superfoods’ or crossword puzzles! alzheimers.org.uk/research
  • 6. Press • Really clear • General messaging • No specifics • No superfoods or crossword puzzles! • Give quotable items – nice sounding messages. alzheimers.org.uk/research
  • 7. Jo Brodie – Diabetes UK • Islet cell transplants in Type 1 diabetes. • background to Type 1 diabetes • What is islet cell transplant? • Is it a ‘miracle cure’?
  • 8. Making a personal choice Kelly Edwards Research Information Co-ordinator Motor Neurone Disease Association Kelly.edwards@mndassociation.org
  • 9. The role of patient organisations • Patient organisation role to provide the facts about unproven/off-label treatments • Allow people to make a well-informed personal choice
  • 10. Eg: Off-label lithium and MND • Lithium is already prescribed as a mood- stabilising drug for mood-related disorders • Available off-label • Interest in lithium for MND from a patient’s perspective sky rocketed when a poorly designed trial published their ‘amazing’ results.
  • 11. President of the Person with MND, royal college of who took lithium off physicians label. "That's easy to say "While the when you're not the information is one faced with the encouraging, it's decision.” important to await results of clinical trials because the Patient "I'm willing to take the medicine has Organisations bridge chance if I understand the serious side-effects the gap between which could science and the risk.” people affected by potentially make disease and the some of the symptoms worse." medical profession.
  • 12. ALSUntangled • ALSUntangled use social networking to bring patients, clinicians, and scientists together for investigation of alternative or off-label MND Treatments. • 15 investigations completed, including X-Cell stem cell clinic, Bee Venom therapy and coconut oil. • Results are published in the journal ALS, are open access and are written in an accessible way.
  • 13. Summary • Opinion on unproven treatments changes with perspective – this is important to bear in mind when tackling unproven or off-label treatment stories. • Patient organisations understand both why people would want to pursue these options, as well as why people should be careful. • As well as patient organisations, resources such as those created by ALSUntangled provide the sort of objective information that helps people to come to an informed choice on whether or not to pursue alternative approaches to treating their disease.
  • 14. Donating your body to medical science Funded by UCL Public Engagement Dr Jenny Gimpel
  • 15. Would you donate your body to medicine after your death? If so, how do you go about it? Why do medical schools need human bodies? What happens to the bodies during and after teaching? Join us for a public discussion on Donating your body to medical science 7.30pm Tuesday 20 April 2010 Bloomsbury Suite, Friends House, 173 Euston Road, London, NW1 2BJ Speakers include: Vishy Mahadevan, Royal College of Surgeons Wendy Birch, University College London Louise Evans, London Anatomy Office Shaun Griffin, Human Tissue Authority To register for a place, please contact Jenny Gimpel on tel: 07855 788985, email: jennygimpel@gmail.com. The event is free, but places are on a first-come first-served basis. Refreshments will be provided. Doors open at 7pm. Nearest tube stations Euston and Euston Square. Wheelchair access, induction loops fitted.
  • 17. Importance of consent and informing family Possibility of rejection if donation unsuitable Bodies increasingly used in surgical training Military medics train on human cadavers
  • 18. How many bodies are donated and are there enough? What do you do with the bodies? What if you have a donor card as well as a consent form? Is diabetes a criterion for rejection? Why don’t you take obese bodies to practice surgery on, given the current health problem?
  • 19. Public – Rejection was biggest issue “Hate idea that after deciding to donate, might be refused.” “The subject needs more publicity.” Organisers – Want to do a larger-scale event
  • 20. Initial reluctance within UCL No negative reaction from public Less support from GP surgeries
  • 21. Human Tissue Authority 150 calls a month Donor webpage in top 5 visited No national data on body donations!
  • 22. Thanks to University College London London Anatomy Office Royal College of Surgeons Human Tissue Authority
  • 23. Tissue Access for Patient Benefit (TAPb) Dr Amir Gander Department of Surgery Royal Free Hospital
  • 24. TAPB
  • 25. What we wanted • Public and patients involved with research • Raise awareness • Data from patient/public vs. professional
  • 26. Improving Liver Transplant Outcomes, Your View • We wanted: Clinical professionals/researchers
  • 27. What we got…. Patients/public Clinical professionals/researchers
  • 28. What we learnt • Inflexibility • Patients invited by doctor = doctor • People want to make a difference
  • 29. • Similar title!! • Voting system • Comment boards
  • 30. We have data! 88% After this conference are you more or less likely to donate Yes tissue? No Need more information 8% 4% 1 2 3
  • 31. Patients running away! 47% 41% Patient Professionals Patient Professionals 24% 21% 18% 12% 12% 9% 6% 6% 3% 3% 0% 0% 0% 0% 0% 0% 0% 0% 1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10
  • 32. Conclusions • Data is key • Crucial to influence our research and policy makers: • Patients and public less cautious than professionals • Mutual benefit leads to representative audience • We need to be more representative • Build momentum slowly

Notas do Editor

  1. Introduce everyone that is leading the session Introduce the session format – five minutes for each of us, we can take a couple of questions, then on to the round-table discussions. 10 minutes on each table, then change. New group at a table build on the discussion of the previous group, with the help of the chair at each table. Discussions will be reported back via the blog that has been set up. Time is tight for these sessions, so you can still contribute after the session at the blog too.
  2. Service for supplying Human Tissue for medical researchers who need to test new treatments on human tissue, expediting UCL and trust management to make the process easier need patient and public pressure Link UCL with industry and other universities Concerned with Ethical Issues that leads into need for patient and public involvement
  3. Two events. This is first patients and public influence research outcomes and to realise how important donation is Raise awareness amongst researchers, healthcare professionals in how important it is to link with each other, helped by TAPb. Data to influence policy makers, trust and UCL
  4. Many public and patients few doctors and researchers
  5. The audience were talked at
  6. UCL and NHS are wary of anything perceived as bad publicity. Despite TAPb having positive outcomes. Patients sometimes voice piece of doctors opinion without the knowledge, patient group and association are more important People like to make a difference if they are given the chance……. Sometimes need to come to their own conclusion we need better engagement tools
  7. Basically the same title! This was the theme of how it was organised They reluctantly allowed: Added voting systems to facilitate engagement Comment boards to draw out comments from people
  8. We had related questions to gauge change in opinion shows need for More conferences,
  9. Crucial to influence our research and policy makers: Patients and public less cautious than professionals Mutual benefit leads to representative audience Public and patient opinion is much more powerful than professional Data gives evidence of what policy is needed and how we are failing at engage, giving important information Representative audience takes time to build up, we started with what we knew and adapted each time This is a series of events, and each one builds on the other, now we have professional engagement, we can use that to focus on public/patient Next time the talks will be lead by patients with the odd research theme. Final point: public and patient are very different population and will need to be considered differently……. All with time